{"id":"W4388666218","doi":"10.1016/j.clml.2023.11.001","title":"Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Quality of life (healthcare); Post-hoc analysis; Physical therapy; Internal medicine; Refractory (planetary science); Health related quality of life; Clinical trial; Multiple myeloma; Minimal clinically important difference; Disease; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004909838,0.0006093183,0.00220669,0.00032323,0.000439576,0.00005010321,0.0004414282,0.0005394671,0.0000467615],"category_scores_gemma":[0.02226668,0.0003974439,0.000384057,0.001500555,0.0007288795,0.0001669211,0.0006606962,0.0008105974,0.00006286306],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000909878,"about_ca_system_score_gemma":0.003066636,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0153236,"about_ca_topic_score_gemma":0.002434944,"domain_scores_codex":[0.988627,0.001683508,0.005794048,0.001570521,0.001273219,0.001051722],"domain_scores_gemma":[0.9872255,0.007525782,0.001871606,0.001999625,0.0003250219,0.001052503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03559984,0.005965238,0.384251,0.00009519726,0.001046945,0.001251995,0.002317286,0.000002719436,0.0007849159,0.000007978719,0.001459976,0.5672169],"study_design_scores_gemma":[0.1031621,0.01059349,0.8812061,0.0003262699,0.0001223607,0.00002296158,0.002110538,0.001464078,0.00009334303,0.00007063673,0.0005042554,0.0003238698],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924626,0.0007317145,0.000001282535,0.001720098,0.0004075347,0.003687544,0.0005292386,0.0003230981,0.0001368609],"genre_scores_gemma":[0.9972662,0.0002926953,0.0001588362,0.0004817681,0.0001618318,0.0002255828,0.0007946275,0.00009570244,0.0005227097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.566893,"threshold_uncertainty_score":0.9998478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1184171867158281,"score_gpt":0.4102881281390837,"score_spread":0.2918709414232555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}